Latest News

STAT Plus: Catalyst stock dives, although the fledgling drug maker has no idea why

For the second time in two weeks, Catalyst Pharmaceuticals stock dived substantially, although the drug maker was at a loss to explain the latest drop.

Shares were down as much as 18% on Monday on six times the normal trading volume, prompting the company to issue a statement before the stock market closed to say it is “not aware of any information” that would cause such a decline. Catalyst also reiterated remarks made last month that it believes it has “sufficient resources” for its current activities through next August.

Continue to STAT Plus to read the full story…

Source link




Related posts

Sandalwood mimicking odorant could stimulate hair growth in humans

Newsemia

What we think we know—but might not—pushes us to learn more

Newsemia

Twenty four genetic variants linked to heightened womb cancer risk

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy